Tissue Genesis Applies CE Mark to its Adult Stem Cell Isolation System
Conformity Marking Allows Device to be Marketed Throughout Europe

Tissue Genesis, Inc. announced on November 18, 2008, that the Tissue Genesis Cell Isolation System will be available to the European marketplace. The company’s system successfully completed safety certification testing necessary to complete its declaration of conformity, allowing the company to apply the CE mark. (See the full press release)

A Leading Authority in Adipose Cell Therapy and Delivery Systems

• Tissue Genesis, Inc. brings together industry leaders, including Dr. Stuart Williams, Director of the Cardiovascular Innovation Institute at the University of Louisville School of Medicine.
• Our devices, when approved and available, are expected to improve the lives of thousands with common medical ailments including heart disease and diabetes.
• We believe there is no other system on the market with as much functionality or cost efficiency as our products, when approved and available..

Mid-graft gross morphology of endothelialized (left) and control (right) ePTFE grafts after three month implantation in a canine carotid segmental replacement model.

Tissue Genesis, Inc. Product and Company Overview

Click here to see the other members of the

Tissue Genesis Cell Isolation System

Fully automated and easy to use system, which delivers isolated cells in about an hour without operator intervention.

Cell Isolation System Product Brochures

If you would like additional information about our products, please Email Tissue Genesis, Inc.